The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.
A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.
Specialty pharmacy Burmans last week received the new “Shaping Healthcare Delivery” award at this year’s AmerisourceBergen’s ThinkLive Conference.
Shares of Diplomat Pharmacy officially began trading on Friday at a price that had reached more than $17 per share in mid-afternoon trading.
The Ohio State University, Cardinal Health and State of Ohio Third Frontier Commission on Wednesday announced the completion of a new, $13 million molecular imaging pharmaceuticals center.
Catamaran, a provider of technology and pharmacy benefit management services, on Wednesday announced that it has entered into a definitive agreement to acquire Salveo Specialty Pharmacy.
Boehringer Ingelheim on Wednesday announced that its Striverdi Respimat (olodaterol) inhalation spray in 5-mcg dosage strength is now available by prescription in pharmacies across the United States.
The Pharmaceutical Research and Manufacturers of America on Tuesday released a new report highlighting the number of investigational cancer medicines that did not succeed in clinical trials.
Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.
America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.